It follows that in the current transgenic AD models, the elicitation of the ISR is not accompanied by the enhanced production and accumulation of iAβ, i.e., that in transgenic AD models the elicitation of the ISR is not followed by the activation of the AβPP-independent iAβ production, which remains inoperative. Here, APP is linked to Alzheimer disease.